Benefit of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: Trial sequential analysis

Int J Surg. 2024 May 20. doi: 10.1097/JS9.0000000000001660. Online ahead of print.
No abstract available